LYMPHOPROLIFERATIVE DISEASE IN MICE INFECTED WITH MURINE GAMMAHERPESVIRUS-68

被引:0
|
作者
SUNILCHANDRA, NP [1 ]
ARNO, J [1 ]
FAZAKERLEY, J [1 ]
NASH, AA [1 ]
机构
[1] UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE,ENGLAND
来源
AMERICAN JOURNAL OF PATHOLOGY | 1994年 / 145卷 / 04期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Murine gammaherpesvirus is a natural pathogen of wild rodents. In the laboratory it establishes an infection of epithelial cells and persists in B lymphocytes in a latent form. Inbred mice chronically infected with the virus develop a lymphoproliferative disease (LPD) similar to that seen in patients infected with Epstein-Barr virus. The frequency of LPD over a period of 3 years was 9% of all infected animals, with 50% of these displaying high grade lymphomas. The incidence of LPD was greatly increased when infected mice were treated with cyclosporin A. The majority of mice used in the experiments were BALB/c, although lymphomas were detected in mice on other genetic backgrounds, ie, CBA and B10Br. Lymphomas were associated with both lymphoid and nonlymphoid tissues (liver, lung, and kidney). In all cases of lymphomas studied thus far, there was a mixed B cell (B220+ve) and T cell (CD3+ve) phenotype. The B cells were light chain restricted, indicative of a clonal origin. Variable numbers of virus genome-positive cells were detected by in situ hybridization in and around the lymphomas. In contrast, no lytic antigen-positive cells were detected, indicating that genome-positive cells were either latently infected or undergoing an abortive infection. These observations suggest that murine gammaherpesvirus-infected mice may be an important model to study the pathogenesis of LPD associated with otehr gammaherpesviruses, such as Epstein-Barr virus.
引用
收藏
页码:818 / 826
页数:9
相关论文
共 50 条
  • [31] Influence of Daily Running Wheel Activity on Immune Response to Infection with Murine Gammaherpesvirus-68
    Jung, Alan P.
    Gasper-Smith, Nancy
    Bost, Kenneth L.
    Turner, Michael J.
    Lightfoot, J. Timothy
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2006, 38 (05): : S31 - S31
  • [32] Murine gammaherpesvirus-68 infection alters self-antigen presentation and type 1 diabetes onset in NOD mice
    Smith, Katherine A.
    Efstathiou, Stacey
    Cooke, Anne
    JOURNAL OF IMMUNOLOGY, 2007, 179 (11): : 7325 - 7333
  • [33] The Murine Gammaherpesvirus-68 gp150 Acts as an Immunogenic Decoy to Limit Virion Neutralization
    Gillet, Laurent
    May, Janet S.
    Colaco, Susanna
    Stevenson, Philip G.
    PLOS ONE, 2007, 2 (08):
  • [34] Murine gammaherpesvirus-68 ORF28 encodes a non-essential virion glycoprotein
    May, JS
    Coleman, HM
    Boname, JM
    Stevenson, PG
    JOURNAL OF GENERAL VIROLOGY, 2005, 86 : 919 - 928
  • [35] PKC theta is not essential for T cell-mediated clearance of murine gammaherpesvirus-68 (MHV-68)
    Giannoni, F
    Lyon, A
    Wareing, M
    Dias, P
    Sarawar, S
    FASEB JOURNAL, 2005, 19 (04): : A401 - A401
  • [36] Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice
    Virgin, HW
    Presti, RM
    Li, XY
    Liu, C
    Speck, SH
    JOURNAL OF VIROLOGY, 1999, 73 (03) : 2321 - 2332
  • [37] Ecstasy (3,4-methylenedioxymethamphetamine) limits murine gammaherpesvirus-68 induced monokine expression
    Nelson, Daniel A.
    Nirmaier, Jamie L.
    Singh, Sam J.
    Tolbert, Melanie D.
    Bost, Kenneth L.
    BRAIN BEHAVIOR AND IMMUNITY, 2008, 22 (06) : 912 - 922
  • [38] The effect of Isoprinosine treatment on persistent infection of Balb/c mice infected with murine gammaherpesvirus 68
    Janickova, O.
    Ancicova, L.
    Briestenska, K.
    Mistrikova, J.
    ACTA VIROLOGICA, 2017, 61 (01) : 32 - 38
  • [39] Characterization of tumor cell lines derived from murine gammaherpesvirus-68-infected mice
    Usherwood, EJ
    Stewart, JP
    Nash, AA
    JOURNAL OF VIROLOGY, 1996, 70 (09) : 6516 - 6518
  • [40] Forced lytic replication impairs host colonization by a latency-deficient mutant of murine gammaherpesvirus-68
    May, JS
    Coleman, HM
    Smillie, B
    Efstathiou, S
    Stevenson, PG
    JOURNAL OF GENERAL VIROLOGY, 2004, 85 : 137 - 146